I couldn't disagree more. Everything in Theranos' marketing and PR collateral was all about finger-pricks and nanotainers. And it was all one big fat lie. You couldn't pay me to take a blood test at one of their facilities.

They weren't "clear" on this. They said were all about their proprietary technology and getting everything from a pinprick when it turns out they weren't doing any of that.

It's like saying I have a great story to tell you but then reading you Moby Dick.

> when it turns out they weren't doing any of that

Except for the part where they had all 200 tests going through lab review... Is the doubt that they'll move on to getting more tests FDA approved once the first one passes full review?

They never once said they were not using existing machines to do these tests, not once, they only spoke about the quantity of the sample needed. Using the same analogy, saying I have a great story to tell you but then reading Moby Dick isn't necessarily cheating, because Moby Dick is a great story :).

Right, it's not cheating or lying, just kinda misleading.

Agreed, they should have been upfront on what technology they developed in house and what it can and cannot do. A simple table outlining that could have cleared up the air.